No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina / NY / Florida       

AAOS Releases Trends and Outcomes from the Registry Program

Eighth annual report of the American Joint Replacement Registry reveals demographic and outcome analysis by COVID-19 status. New AAOS Patient-Facing Registry Report helps patients better understand physician recommendations

Editor: What To Know

  • The AAOS Patient-Facing Registry Report provides a general registry overview and features information on the musculoskeletal health data captured by each of the registries in the AAOS Registry Program, which, as of March 2022, contains data from over 1,400 institutions across the U.
  • “Last year, we added ICD-10 coding to the AAOS Registry Program with the goal of monitoring the impact of COVID-19 on outcomes, trends of surgery based on the pause in elective surgery, and the trends of patient-reported outcomes due to delayed procedures.
  • “With the publication of the AAOS Patient-Facing Registry Report, I realize that I can play a meaningful role in improving care for myself and future surgery patients by participating in the surveys provided by my healthcare provider,”.

AAOS Registry Program is pleased to announce the availability of two new clinical data reports – the American Joint Replacement Registry (AJRR) 2021 Annual Report Supplement and the AAOS Patient-Facing Registry Report.

These reports, which were released during the AAOS 2022 Annual Meeting in Chicago, offer actionable information to guide physician and patient decision-making to improve care.

AJRR 2021 Annual Report Supplement
AJRR is the largest orthopaedic registry in the world based on annual procedures submitted. Data presented in the AJRR 2021 Annual Report Supplement were submitted to the AJRR by 1,152 institutions through June 2021, covering procedures from 2012 to 2020. For the third consecutive year, the supplement includes reporting of device-specific cumulative percent revision estimates, drawn from the registry’s unique linkage with Centers for Medicare & Medicaid Services (CMS) claims data. This year’s analysis also examines data from patients with a prior diagnosis of COVID-19 whose information was submitted to the AJRR through the capture of appropriate ICD-10 coding.

“The AJRR Supplement provides the most comprehensive picture to-date of patterns of hip and knee arthroplasty practice and outcomes in the United States,” said James A. Browne, MD, FAAOS, chair of the AJRR Publications Subcommittee and editor of AJRR Publications. “Last year, we added ICD-10 coding to the AAOS Registry Program with the goal of monitoring the impact of COVID-19 on outcomes, trends of surgery based on the pause in elective surgery, and the trends of patient-reported outcomes due to delayed procedures. This report not only offers a look at the initial data as it relates to quality of care, but also previews the impact of COVID-19 on CMS value-based payment models and coverage for patients recovering from COVID-19.”

While patient numbers were limited in the COVID-19 cohort (n=296), the unadjusted rate of 90-day readmission was significantly lower compared to the non-COVID-19 group (1.4% and 4.3%, respectively; p=0.013). No significant relationship was found between 90-mortality and COVID-19 status (p=0.41).

“Although preliminary and not risk adjusted, this data is a first look at COVID and its impact on hip and knee arthroplasty and should provide some degree of reassurance to clinicians and patients,” said Dr. Browne.

To read and download the AJRR 2021 Annual Report Supplement, visit the AAOS’ website.

AAOS Patient-Facing Registry Report
The AAOS Patient-Facing Registry Report provides a general registry overview and features information on the musculoskeletal health data captured by each of the registries in the AAOS Registry Program, which, as of March 2022, contains data from over 1,400 institutions across the U.S. and the District of Columbia. While a registry serves to collect data about procedures, analysis of that data can help surgeons choose individualized treatments and implantable devices that are best for their patients.

In addition to providing high-level summaries of injuries, diseases, and procedures collected within the registry, this report includes information about patient-reported outcome measures (PROMs), which are surveys used to capture outcomes, or a patient’s pre- and post-operative health status, from their perspective.

“With the publication of the AAOS Patient-Facing Registry Report, I realize that I can play a meaningful role in improving care for myself and future surgery patients by participating in the surveys provided by my healthcare provider,” said AAOS Public Advisory Board Member Richard Seiden. “The report aggregates my responses with others’ to help surgeons and clinical teams to monitor patients’ recovery, pain levels, and return to daily activities. My survey responses provide direct personal input into a larger quality improvement effort and – over time – help to improve the processes, protocols, device selection, and recovery techniques available to other patients in the future.”

For additional information about the role of clinical data registries play in improving patient outcomes and the quality of orthopaedic care, patients can visit OrthoInfo.org. OrthoInfo features a variety of patient education articles that highlight general trends in hip and knee procedures, as well as surgeon and patient perspectives on how to best prepare for pre-, day-of, and post-surgical needs.

To read and download the complete report, visit the AAOS’ website.

AAOS Registry Program
The AAOS Registry Program’s mission is to improve orthopaedic care through the collection, analysis, and reporting of actionable data. The American Joint Replacement Registry (AJRR), the Academy’s hip and knee replacement registry, is the cornerstone of the AAOS’s Registry Program, and the world’s largest national registry of hip and knee joint replacement data by annual procedural count, with more than 2.4 million procedures contained within its database. Additional registries include the Fracture & Trauma Registry, the Musculoskeletal Tumor Registry (MsTR), the Shoulder & Elbow Registry (SER), and the American Spine Registry (ASR), a collaborative effort between the American Association of Neurological Surgeons (AANS) and the AAOS.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy